Equity Market Research
Friday 23 February 2018
AJANTA PHARMA: Growth ingredients in place; EM execution + US approvals hold key says Motilal Oswal https://goo.gl/A57bFi
AJANTA PHARMA: Growth ingredients in place; EM execution + US approvals hold key says Motilal Oswal https://goo.gl/A57bFi
https://goo.gl/A57bFi
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment